Echocardiography = POCUS
POCUS = Echocardiography
John H. Alexander, MD, MHS
Professor of Medicine/Cardiology
Duke Health
Disclosures
• Echocardiography supports my salary.
• I did POCUS research in 2004.
• Research Funding: Artivion/CryoLife, Bayer, Bristol-Myers Squibb, CSL Behring, Ferring, the
U.S. FDA, Humacyte, and the U.S. NIH.
• Consulting: AbbVie, Arrowhead, Artivion/CryoLife, AtriCure, Bayer, Bristol-Myers Squibb,
Curis, Eli Lilly, Ferring, GlaxoSmithKline, Janssen, Novostia, Pfizer, Portola, Theravance, and
Veralox.
AmHeart J2004;147:476–81
Evolution of Echocardiography
$100 $300,000 $30,000 $3,000 $300
?
Future
Echocardiography = cPOCUS
High
Low
“Quality”
POCUS
More Focused
More Real Time
Echocardiography
More Comprehensive
More Scheduled
Diagnostic Testing 101

Echocardiography = POCUS; POCUS = Echocardiography